Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

Protein structure prediction on the Web: a case study using the Phyre server

Kelley, L. A., & Sternberg, M. J. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.2 · Cited by 4,154 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

The Immune Epitope Database (IEDB): 2018 update

Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S. R., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1006 · Cited by 2,194 · see citing works

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887 · see citing works

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790 · cited 3× · see citing works

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works

NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data

Jurtz, V. I., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,476 · see citing works

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310 · see citing works

Distinct conformational states of SARS-CoV-2 spike protein

Cai, Y., Zhang, J., Xiao, T., Peng, H., Sterling, S. M., Walsh, R. M., Rawson, S., Rits-Volloch, S., & Chen, B. (2020) · Science · doi:10.1126/science.abd4251 · Cited by 1,221 · see citing works

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179 · see citing works

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120 · see citing works

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

Goulder, P., Phillips, R. E., Colbert, R. A., McAdam, S. N., Ogg, G. S., Nowak, M. A., Giangrande, P. L. F., Luzzi, G. A., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,115 · see citing works

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

Bui, H., Sidney, J., Dinh, K., Southwood, S., Newman, M. J., & Sette, A. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-153 · Cited by 986 · see citing works

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Weiskopf, D., Schmitz, K. S., Raadsen, M. P., Grifoni, A., Okba, N. M. A., Endeman, H., van den Akker, J. P. C., Molenkamp, R., Koopmans, M. P. G., van Gorp, E. C. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2071 · Cited by 907 · see citing works

Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools

Gonzalez-Galarza, F. F., McCabe, A., Santos, E. J. M. D., Jones, J., Takeshita, L., Ortega-Rivera, N. D., Cid-Pavon, G. M. D., Ramsbottom, K., Ghattaoraya, G., Alfirevic, A., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1029 · Cited by 731 · see citing works

Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

Shrock, E., Fujimura, E., Kula, T., Timms, R. T., Lee, I.-H., Leng, Y., Robinson, M. L., Sie, B. M., Li, M. Z., Chen, Y., et al. (2020) · Science · doi:10.1126/science.abd4250 · Cited by 678 · see citing works

Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires

Southwood, S., Sidney, J., Kondo, A., del Guercio, M., Appella, E., Hoffman, S. L., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3363 · Cited by 665 · see citing works

An Infectious cDNA Clone of SARS-CoV-2

Xie, X., Muruato, A., Lokugamage, K. G., Narayanan, K., Zhang, X., Zou, J., Liu, J., Schindewolf, C., Bopp, N. E., Aguilar, P. V., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.004 · Cited by 647 · see citing works

Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells

Weiskopf, D., Angelo, M. A., de Azeredo, E. L., Sidney, J., Greenbaum, J., Fernando, A. N., Broadwater, A. H., Kolla, R. V., Silva, A. D. D., de Silva, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305227110 · Cited by 625 · see citing works

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

Stadlbauer, D., Amanat, F., Chromikova, V., Jiang, K., Strohmeier, S., Arunkumar, G. A., Tan, J., Bhavsar, D., Capuano, C., Roubidoux, E. K., et al. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.100 · Cited by 623 · see citing works

YASARA: A Tool to Obtain Structural Guidance in Biocatalytic Investigations

Land, H., & Humble, M. S. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7366-8_4 · Cited by 614 · see citing works

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00808-x · Cited by 582 · see citing works

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

Meckiff, B. J., Ramírez-Suástegui, C., Fajardo, V., Chee, S., Kusnadi, A., Simon, H. A., Eschweiler, S., Grifoni, A., Pelosi, E., Weiskopf, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.001 · Cited by 565 · see citing works

Biochemical characterization of SARS-CoV-2 nucleocapsid protein

Zeng, W., Liu, G., Ma, H., Zhao, D., Yang, Y., Liu, M., Mohammed, A., Zhao, C., Yang, Y., Xie, J., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.136 · Cited by 480 · see citing works

Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes

Greenbaum, J., Sidney, J., Chung, J., Brander, C., Peters, B., & Sette, A. (2011) · Immunogenetics · doi:10.1007/s00251-011-0513-0 · Cited by 449 · see citing works

IEDB-AR: immune epitope database-analysis resource in 2019

Dhanda, S. K., Mahajan, S., Paul, S., Yan, Z., Kim, H., Jespersen, M. C., Jurtz, V., Andreatta, M., Greenbaum, J. A., Marcatili, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz452 · Cited by 427 · see citing works

Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells

Reiss, S., Baxter, A. E., Cirelli, K. M., Dan, J. M., Morou, A., Daigneault, A., Brassard, N., Silvestri, G., Routy, J.-P., Havenar-Daughton, C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186998 · Cited by 343 · see citing works

Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein

Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N., Perullo, C. R., Cristofaro, A. W., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.006 · Cited by 318 · see citing works

HLA Class I Alleles Are Associated with Peptide-Binding Repertoires of Different Size, Affinity, and Immunogenicity

Paul, S., Weiskopf, D., Angelo, M. A., Sidney, J., Peters, B., & Sette, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302101 · Cited by 299 · see citing works

TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates

Paul, S., Sidney, J., Sette, A., & Peters, B. (2016) · Current Protocols in Immunology · doi:10.1002/cpim.12 · Cited by 274 · see citing works

NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ

Karosiene, E., Rasmussen, M., Blicher, T. H., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272 · see citing works

T Cell Epitope Predictions

Peters, B., Nielsen, M., & Sette, A. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082119-124838 · Cited by 268 · see citing works

Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset

Arlehamn, C. S. L., Gerasimova, A. V., Mele, F., Henderson, R., Swann, J., Greenbaum, J., Kim, Y., Sidney, J., James, E. A., Taplitz, R., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003130 · Cited by 266 · see citing works

SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection

Altmann, D., & Boyton, R. (2020) · Science immunology · doi:10.1126/sciimmunol.abd6160 · Cited by 255 · see citing works

A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood

Dan, J. M., Arlehamn, C. S. L., Weiskopf, D., Antunes, R. D. S., Havenar‐Daughton, C., Reiss, S. M., Brigger, M., Bothwell, M., Sette, A., & Crotty, S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600318 · Cited by 248 · see citing works

Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population LevelsPreprint

Snyder, T. M., Gittelman, R. M., Klinger, M., et al. (2020) · medRxiv · doi:10.1101/2020.07.31.20165647 · Cited by 234 · see citing works

Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes

Paul, S., Arlehamn, C. S. L., Scriba, T. J., Dillon, M., Oseroff, C., Hinz, D., McKinney, D. M., Pro, S. C., Sidney, J., Peters, B., et al. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.03.022 · Cited by 209 · see citing works

Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels

Snyder, T. M., Gittelman, R. M., Klinger, M., May, D., Osborne, E. J., Taniguchi, R. T., Zahid, H. J., Kaplan, I. M., Dines, J. N., Noakes, M. T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1488860 · Cited by 206 · see citing works

Selective CD4+ T Cell Help for Antibody Responses to a Large Viral Pathogen: Deterministic Linkage of Specificities

Sette, A., Moutaftsi, M., Moyron-Quiroz, J., McCausland, M. M., Davies, D. H., Johnston, R. J., Peters, B., Rafii-El-Idrissi Benhnia, M., Hoffmann, J., Su, H.-P., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.04.018 · Cited by 168 · see citing works

A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans

Arlehamn, C. S. L., McKinney, D. M., Carpenter, C., Paul, S., Rozot, V., Makgotlho, E., Gregg, Y., van Rooyen, M., Ernst, J., Hatherill, M., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005760 · Cited by 158 · see citing works

Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen

Oseroff, C., Sidney, J., Kotturi, M. F., Kolla, R. V., Alam, R., Broide, D. H., Wasserman, S. I., Weiskopf, D., McKinney, D. M., Chung, J. L., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000405 · Cited by 146 · see citing works

Human CD8+T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets

Weiskopf, D., Cerpas, C., Angelo, M. A., Bangs, D. J., Sidney, J., Paul, S., Peters, B., Sanches, F. P. S., Silvera, C. G. T., Costa, P. R., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv289 · Cited by 135 · see citing works

Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture

Sidney, J., Southwood, S., Moore, C., Oseroff, C., Pinilla, C., Grey, H. M., & Sette, A. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1803s100 · Cited by 133 · see citing works

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Keller, M. D., Harris, K. M., Jensen-Wachspress, M. A., Kankate, V. V., Lang, H., Lazarski, C. A., Durkee-Shock, J. R., Lee, P., Chaudhry, K., Webber, K., et al. (2020) · Blood · doi:10.1182/blood.2020008488 · Cited by 122 · see citing works

High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19

Schub, D., Klemis, V., Schneitler, S., Mihm, J., Lepper, P. M., Wilkens, H., Bals, R., Eichler, H., Gärtner, B. C., Becker, S. L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142167 · Cited by 113 · see citing works

Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Proteins by Machine Learning and Physics-Based RefinementPreprint

Heo, L., & Feig, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.25.008904 · Cited by 96 · see citing works

Footprints of antigen processing boost MHC class II natural ligand predictions

Barra, C., Alvarez, B., Paul, S., Sette, A., Peters, B., Andreatta, M., Buus, S., & Nielsen, M. (2018) · Genome Medicine · doi:10.1186/s13073-018-0594-6 · Cited by 88 · see citing works

Automatic Generation of Validated Specific Epitope Sets

Pro, S. C., Sidney, J., Paul, S., Arlehamn, C. S. L., Weiskopf, D., Peters, B., & Sette, A. (2015) · Journal of Immunology Research · doi:10.1155/2015/763461 · Cited by 79 · see citing works

Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas

Grifoni, A., Angelo, M. A., Lopez, B., O’Rourke, P., Sidney, J., Cerpas, C., Balmaseda, Á., Silveira, C. G. T., Maestri, A., Costa, P. R., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01309 · Cited by 78 · see citing works

Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands

Paul, S., Karosiene, E., Dhanda, S. K., Jurtz, V. I., Edwards, L., Nielsen, M., Sette, A., & Peters, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01795 · Cited by 50 · see citing works

ImmunomeBrowser: a tool to aggregate and visualize complex and heterogeneous epitopes in reference proteins

Dhanda, S. K., Vita, R., Ha, B., Grifoni, A., Peters, B., & Sette, A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty463 · Cited by 42 · see citing works

Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin

Cassotta, A., Paparoditis, P., Geiger, R., Mettu, R. R., Landry, S. J., Donati, A., Benevento, M., Foglierini, M., Lewis, D. J. M., Lanzavecchia, A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200206 · Cited by 36 · see citing works

Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions

Paul, S., Grifoni, A., Peters, B., & Sette, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03151 · Cited by 33 · see citing works

Identification and Characterization of CD4 + T Cell Epitopes after Shingrix Vaccination

Voic, H., de Vries, R. D., Sidney, J., Rubiro, P., Moore, E. C., Phillips, E. J., Mallal, S. A., Schwan, B., Weiskopf, D., Sette, A., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01641-20 · Cited by 31 · see citing works

Development and Validation of a Bordetella pertussis Whole‐Genome Screening Strategy

Antunes, R. D. S., Quiambao, L. G., Sutherland, A., Soldevila, F., Dhanda, S. K., Armstrong, S. K., Brickman, T. J., Merkel, T. J., Peters, B., & Sette, A. (2020) · Journal of Immunology Research · doi:10.1155/2020/8202067 · Cited by 28 · see citing works

Positional Bias of MHC Class I Restricted T-Cell Epitopes in Viral Antigens Is Likely due to a Bias in Conservation

Kim, Y., Yewdell, J. W., Sette, A., & Peters, B. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002884 · Cited by 13 · see citing works

Adaptive immunity to SARS-CoV-2 and COVID-19

Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860 · see citing works

SARS-CoV-2 variant biology: immune escape, transmission and fitness

Carabelli, A. M., Peacock, T. P., Thorne, L., Harvey, W. T., Hughes, J., de Silva, T. I., Peacock, S. J., Barclay, W., de Silva, T. I., Towers, G. J., et al. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00841-7 · Cited by 1,293 · see citing works

The T cell immune response against SARS-CoV-2

Moss, P. A. H. (2022) · Nature Immunology · doi:10.1038/s41590-021-01122-w · Cited by 1,205 · see citing works

The biological and clinical significance of emerging SARS-CoV-2 variants

Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009 · see citing works

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · Science · doi:10.1126/science.abm0829 · Cited by 873 · see citing works

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

Tarke, A., Coelho, C. H., Zhang, Z., Dan, J. M., Yu, E. D., Methot, N., Bloom, N. I., Goodwin, B., Phillips, E., Mallal, S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.015 · Cited by 858 · see citing works

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., Wang, E., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100355 · Cited by 706 · see citing works

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

Network for Genomic Surveillance in South Africa, Cele, S., COMMIT-KZN Team, Gazy, I., Jackson, L., Hwa, S.-H., Tegally, H., Lustig, G., Giandhari, J., Pillay, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03471-w · Cited by 651 · see citing works

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

Keeton, R. S., Tincho, M. B., Ngomti, A., Baguma, R., Benede, N., Suzuki, A., Khan, K., Cele, S., Bernstein, M. P., Karim, F., et al. (2022) · Nature · doi:10.1038/s41586-022-04460-3 · Cited by 611 · see citing works

Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531 · see citing works

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

Apostolidis, S. A., Kakara, M., Painter, M. M., Goel, R. R., Mathew, D., Lenzi, K., Rezk, A., Patterson, K. R., Espinoza, D. A., Kadri, J. C., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01507-2 · Cited by 500 · see citing works

Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination

Painter, M. M., Mathew, D., Goel, R. R., Apostolidis, S. A., Pattekar, A., Kuthuru, O., Baxter, A. E., Herati, R. S., Oldridge, D. A., Gouma, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.001 · Cited by 499 · see citing works

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

Swadling, L., Diniz, M. O., Schmidt, N. M., Amin, O. E., Chandran, A., Shaw, E., Pade, C., Gibbons, J. M., Bert, N. L., Tan, A. T., et al. (2021) · Nature · doi:10.1038/s41586-021-04186-8 · Cited by 384 · see citing works

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19

Grifoni, A., Sidney, J., Vita, R., Peters, B., Crotty, S., Weiskopf, D., & Sette, A. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.010 · Cited by 314 · see citing works

SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans

Mudd, P. A., Minervina, A. A., Pogorelyy, M. V., Turner, J. S., Kim, W., Kalaidina, E., Petersen, J., Schmitz, A. J., Lei, T., Haile, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.12.026 · Cited by 302 · see citing works

Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic

Khandia, R., Singhal, S., Alqahtani, T., Kamal, M. A., El-Shall, N. A., Nainu, F., Desingu, P. A., & Dhama, K. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112816 · Cited by 300 · see citing works

SARS-CoV-2 Variants, Vaccines, and Host Immunity

Mistry, P., Barmania, F., Mellet, J., Peta, K. T., Strydom, A., Viljoen, I. M., James, W., Gordon, S., & Pepper, M. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809244 · Cited by 293 · see citing works

Correlates of protection against SARS ‐ CoV ‐2 infection and COVID‐19 disease

Goldblatt, D., Alter, G., Crotty, S., & Plotkin, S. A. (2022) · Immunological Reviews · doi:10.1111/imr.13091 · Cited by 290 · see citing works

Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

Loyal, L., Braun, J., Henze, L., Kruse, B., Dingeldey, M., Reimer, U., Kern, F., Schwarz, T., Mangold, M., Unger, C., et al. (2021) · Science · doi:10.1126/science.abh1823 · Cited by 283 · see citing works

Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection

Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., García-Valtanen, P., Al-Delfi, Z., Gummow, J., Ferguson, C. C., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02228-6 · Cited by 278 · see citing works

Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines

Sette, A., & Crotty, S. (2022) · Immunological Reviews · doi:10.1111/imr.13089 · Cited by 266 · see citing works

The germinal centre B cell response to SARS-CoV-2

Laidlaw, B. J., & Ellebedy, A. H. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00657-1 · Cited by 250 · see citing works

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Heitmann, J. S., Bilich, T., Tandler, C., Nelde, A., Maringer, Y., Marconato, M., Reusch, J., Jäger, S., Denk, M., Richter, M., et al. (2021) · Nature · doi:10.1038/s41586-021-04232-5 · Cited by 250 · see citing works

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients

Saini, S. K., Hersby, D. S., Tamhane, T., Povlsen, H. R., Hernandez, S. P. A., Nielsen, M., Gang, A. O., & Hadrup, S. R. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf7550 · Cited by 222 · see citing works

SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells

Minervina, A. A., Pogorelyy, M. V., Kirk, A. M., Crawford, J. C., Allen, E. K., Chou, C., Mettelman, R. C., Allison, K., Lin, C.-Y., Brice, D. C., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01184-4 · Cited by 210 · see citing works

COVID-19 vaccination: The road ahead

Altmann, D. M., & Boyton, R. J. (2022) · Science · doi:10.1126/science.abn1755 · Cited by 195 · see citing works

Imprinted SARS-CoV-2-Specific Memory Lymphocytes Define Hybrid Immunity

Rodda, L. B., Morawski, P. A., Pruner, K. B., Fahning, M. L., Howard, C. A., Franko, N., Logue, J. K., Eggenberger, J., Stokes, C., Golez, I., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.018 · Cited by 191 · see citing works

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines

McLean, G. R., Kamil, J. P., Lee, B., Moore, P. L., Schulz, T. F., Muik, A., Şahin, U., Türeci, Ö., & Pather, S. (2022) · mBio · doi:10.1128/mbio.02979-21 · Cited by 190 · see citing works

T Cell Responses to SARS-CoV-2

Sette, A., Sidney, J., & Crotty, S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-061120 · Cited by 181 · see citing works

Predicting the mutational drivers of future SARS-CoV-2 variants of concern

Maher, M. C., Bartha, I., Weaver, S., di Iulio, J., Ferri, E., Soriaga, L. B., Lempp, F. A., Hie, B., Bryson, B. D., Berger, B., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk3445 · Cited by 178 · see citing works

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

Woldemeskel, B. A., Garliss, C. C., & Blankson, J. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149335 · Cited by 175 · see citing works

SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 ⁺ T cell responses

Agerer, B., Koblischke, M., Gudipati, V., Montaño-Gutierrez, L. F., Smyth, M., Popa, A., Genger, J.-W., Endler, L., Florian, D. M., Mühlgrabner, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg6461 · Cited by 172 · see citing works

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Bilich, T., Nelde, A., Heitmann, J. S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Hörber, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7517 · Cited by 147 · see citing works

Adaptive Immune Responses and Immunity to SARS-CoV-2

Primorac, D., Vrdoljak, K., Brlek, P., Pavelić, E., Molnar, V., Matišić, V., Ivkošić, I. E., & Parčina, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848582 · Cited by 151 · see citing works

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L. R., Chen, D.-Y., Gallagher, K. M. E., Bauer, M. R., Taylor, H. B., Dunn, W. A., Tarr, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.046 · Cited by 147 · see citing works

Scientific rationale for developing potent RBD-based vaccines targeting COVID-19

Kleanthous, H., Silverman, J., Makar, K., Yoon, I., Jackson, N. A. C., & Vaughn, D. (2021) · npj Vaccines · doi:10.1038/s41541-021-00393-6 · Cited by 137 · see citing works

Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2

Low, J. S., Vaqueirinho, D., Mele, F., Foglierini, M., Jerak, J., Perotti, M., Jarrossay, D., Jovic, S., Perez, L. H., Cacciatore, R., et al. (2021) · Science · doi:10.1126/science.abg8985 · Cited by 131 · see citing works

Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes

Gfeller, D., Schmidt, J., Croce, G., Guillaume, P., Bobisse, S., Genolet, R., Queiroz, L., Cesbron, J., Racle, J., & Harari, A. (2023) · Cell Systems · doi:10.1016/j.cels.2022.12.002 · Cited by 122 · see citing works

T‐cell activation–induced marker assays in health and disease

Poloni, C., Schonhofer, C., Ivison, S. M., Levings, M. K., Steiner, T. S., & Cook, L. E. (2023) · Immunology and Cell Biology · doi:10.1111/imcb.12636 · Cited by 121 · see citing works

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity

Mengist, H. M., Kombe, A. J. K., Mekonnen, D. S., Abebaw, A., Getachew, M., & Jin, T. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101533 · Cited by 112 · see citing works

Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity

Riou, C., Keeton, R., Moyo-Gwete, T., Hermanus, T., Kgagudi, P., Baguma, R., Valley‐Omar, Z., Smith, M., Tegally, H., Doolabh, D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj6824 · Cited by 104 · see citing works

Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals

Tan, A. T., Lim, J. M. E., Bert, N. L., Kunasegaran, K., Chia, A., Qui, M., Tan, N., Chia, W. N., de Alwis, R., Ying, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152379 · Cited by 106 · see citing works

Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection

Painter, M. M., Johnston, T. S., Lundgreen, K. A., Santos, J. J. S., Qin, J. S., Goel, R. R., Apostolidis, S. A., Mathew, D., Fulmer, B., Williams, J. C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01613-y · Cited by 106 · see citing works

Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation

King, C., & Sprent, J. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.02.003 · Cited by 101 · see citing works

CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants

Redd, A. D., Nardin, A., Kared, H., Bloch, E. M., Pekosz, A. S., Laeyendecker, O. B., Abel, B., Fehlings, M., Quinn, T. C., & Tobian, A. A. R. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab143 · Cited by 105 · see citing works

HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens

Fischer, W., Giorgi, E. E., Chakraborty, S., Nguyen, K., Tanmoy Bhattacharya, A., Theiler, J. P., Goloboff, P. A., Yoon, H., Abfalterer, W., Foley, B. T., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.012 · Cited by 106 · see citing works

The COVID-19 pandemic: viral variants and vaccine efficacy

Ciotti, M., Ciccozzi, M., Pieri, M., & Bernardini, S. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1979462 · Cited by 108 · see citing works

T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant

Choi, S. J., Kim, D.-U., Noh, J. Y., Kim, S., Park, S., Jeong, H. W., & Shin, E. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00838-5 · Cited by 104 · see citing works

A streamlined platform for analyzing tera-scale DDA and DIA mass spectrometry data enables highly sensitive immunopeptidomics

Xin, L., Qiao, R., Chen, X., Tran, N. H., Pan, S., Rabinoviz, S., Bian, H., He, X., Morse, B., Shan, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30867-7 · Cited by 101 · see citing works

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV

Vergori, A., Cozzi‐Lepri, A., Cicalini, S., Matusali, G., Bordoni, V., Lanini, S., Meschi, S., Iannazzo, R., Mazzotta, V., Colavita, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32263-7 · Cited by 95 · see citing works

Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8 + T cell repertoire upon viral exposurePreprint

Francis, J. M., Leistritz-Edwards, D., Dunn, A., Tarr, C., Lehman, J. W., Dempsey, C., Hamel, A., Rayon-Estrada, V., Liu, G., Wang, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1126/sciimmunol.abk3070 · Cited by 90 · see citing works

Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q

Wilhelm, A., Toptan, T., Pallas, C., Wolf, T., Goetsch, U., Gottschalk, R., Vehreschild, M. J. G. T., Ciesek, S., & Widera, M. (2021) · Viruses · doi:10.3390/v13091693 · Cited by 86 · see citing works

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection

Arieta, C. M., Xie, Y. J., Rothenberg, D., Diao, H., Harjanto, D., Meda, S., Marquart, K., Koenitzer, B., Sciuto, T. E., Lobo, A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.007 · Cited by 85 · see citing works

Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro

Widera, M., Wilhelm, A., Hoehl, S., Pallas, C., Kohmer, N., Wolf, T., Rabenau, H. F., Corman, V. M., Drosten, C., Vehreschild, M. J. G. T., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab355 · Cited by 81 · see citing works

Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis

Grifoni, A., Alonzi, T., Alter, G., Noonan, D. M., LANDAY, A. L., Albini, A., & Goletti, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1146704 · Cited by 87 · see citing works

The great escape? SARS-CoV-2 variants evading neutralizing responses

Prévost, J., & Finzi, A. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.010 · Cited by 82 · see citing works

Molecular mimicry and autoimmunity in the time of COVID-19

Rojas, M., Herrán, M., Ramı́rez-Santana, C., Leung, P. S. C., Anaya, J.-M., Ridgway, W. M., & Gershwin, M. E. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103070 · Cited by 80 · see citing works

SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron

Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2022) · Viruses · doi:10.3390/v14010079 · Cited by 81 · see citing works

Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers

Antunes, R. D. S., Pallikkuth, S., Williams, E., Yu, E. D., Mateus, J., Quiambao, L. G., Wang, E. W., Rawlings, S. A., Stadlbauer, D., Jiang, K., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab176 · Cited by 70 · see citing works

B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19

Zollner, A., Watschinger, C., Rössler, A., Farcet, M. R., Penner, A., Böhm, V., Zollner-Kiechl, S., Stampfel, G., Hintenberger, R., Tilg, H., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103539 · Cited by 75 · see citing works

Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells

Parker, R., Partridge, T., Wormald, C., Kawahara, R., Stalls, V., Aggelakopoulou, M., Parker, J., Doherty, R. P., Morejon, Y. A., Lee, E. M., et al. (2020) · bioRxiv · doi:10.1016/j.celrep.2021.109179 · Cited by 78 · see citing works

COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge

Furlan, A., Forner, G., Cipriani, L., Vian, E., Rigoli, R., Gherlinzoni, F., & Scotton, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763412 · Cited by 74 · see citing works

Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection

Gittelman, R. M., Lavezzo, E., Snyder, T. M., Zahid, H. J., Carty, C. L., Elyanow, R., Dalai, S. C., Kirsch, I. R., Baldo, L., Manuto, L., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.151849 · Cited by 74 · see citing works

Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans

Grifoni, A., Zhang, Y., Tarke, A., Sidney, J., Rubiro, P., Reina-Campos, M., Filaci, G., Dan, J. M., Scheuermann, R. H., & Sette, A. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.11.003 · Cited by 72 · see citing works

The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role

Bertoletti, A., Tan, A. T., & Bert, N. L. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab006 · Cited by 67 · see citing works

Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform

Quadeer, A. A., Ahmed, S. F., & McKay, M. R. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100312 · Cited by 66 · see citing works

Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease

Lynch, S. M., Guo, G., Gibson, D. S., Bjourson, A. J., & Singh, T. (2021) · Cells · doi:10.3390/cells10123367 · Cited by 69 · see citing works

Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants

Zhang, H., Deng, S., Ren, L., Zheng, P., Hu, X., Jin, T., & Tan, X. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109708 · Cited by 68 · see citing works

Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults

Ahn, J. Y., Lee, J., Suh, Y. S., Song, Y. G., Choi, Y.-J., Lee, K. H., Seo, S. H., Song, M., Oh, J., Kim, M., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00358-x · Cited by 67 · see citing works

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults

Kared, H., Wolf, A., Alirezaylavasani, A., Ravussin, A., Solum, G., Tran, T. T., Lund‐Johansen, F., Vaage, J. T., Nissen‐Meyer, L. S. H., Nygaard, U. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31888-y · Cited by 65 · see citing works

Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant

Nesamari, R., Omondi, M. A., Baguma, R., Höft, M. A., Ngomti, A., Nkayi, A. A., Besethi, A. S., Magugu, S. F. J., Mosala, P., Walters, A., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2023.12.003 · Cited by 65 · see citing works

Landscape and selection of vaccine epitopes in SARS-CoV-2

Smith, C. C., Olsen, K. S., Gentry, K. M., Sambade, M. J., Beck, W. A., Garness, J. A., Entwistle, S., Willis, C., Vensko, S. P., II, Woods, A., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00910-1 · Cited by 64 · see citing works

Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory

Wragg, K. M., Lee, W. S., Koutsakos, M., Tan, H., Amarasena, T. H., Reynaldi, A., Gare, G., Konstandopoulos, P., Field, K. R., Esterbauer, R., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01175-5 · Cited by 65 · see citing works

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection

Peluso, M. J., Spinelli, M. A., Deveau, T., Forman, C. A., Munter, S. E., Mathur, S., Tang, A. F., Lu, S., Goldberg, S. A., Arreguin, M. I., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003338 · Cited by 64 · see citing works

In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles

Su, F., Zhao, Q. H., Dahotre, S. N., Gamboa, L., Bawage, S. S., Trenkle, A. D. S., Zamat, A. H., Phuengkham, H., Ahmed, R., Santangelo, P. J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm7950 · Cited by 61 · see citing works

T cell immune memory after covid-19 and vaccination

Wang, L., Nicols, A. R., Turtle, L. C. W., Richter, A. G., Duncan, C. J. A., Dunachie, S. J., Klenerman, P., & Payne, R. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000468 · Cited by 61 · see citing works

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of ConcernPreprint

Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.23.457229 · Cited by 59 · see citing works

The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses

Goletti, D., Petrone, L., Manissero, D., Bertoletti, A., Rao, S. N., Ndunda, N., Sette, A., & Nikolayevskyy, V. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.07.005 · Cited by 68 · see citing works

Omicron variant of SARS-CoV-2 harbors a unique insertion mutation of putative viral or human genomic originPreprint

Venkatakrishnan, A., Anand, P., Lenehan, P. J., Suratekar, R., Raghunathan, B., Niesen, M. J. M., & Soundararajan, V. (2021) · doi:10.31219/osf.io/f7txy · Cited by 58 · see citing works

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose

Rénia, L., Goh, Y. S., Rouers, A., Bert, N. L., Chia, W. N., Chavatte, J., Fong, S., Chang, Z. W., Zhuo, N. Z., Tay, M. Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32312-1 · Cited by 58 · see citing works

Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Kang, C. K., Kim, M., Lee, S., Kim, G., Choe, P. G., Park, W. B., Kim, N. J., Lee, C., Kim, I. S., Jung, K., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab159 · Cited by 56 · see citing works

Resolving SARS-CoV-2 CD4+ T cell specificity via reverse epitope discovery

Pogorelyy, M. V., Rosati, E., Minervina, A. A., Mettelman, R. C., Scheffold, A., Franke, A., Bächer, P., & Thomas, P. G. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100697 · Cited by 53 · see citing works

A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity

Cafferty, S. M., Haque, A. K. M. A., Vandierendonck, A., Weidensee, B., Plovyt, M., Stuchlíková, M., François, N., Valembois, S., Heyndríckx, L., Míchiels, J., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.04.014 · Cited by 54 · see citing works

Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors

Tarke, A., Potestà, M., Varchetta, S., Fenoglio, D., Iannetta, M., Sarmati, L., Mele, D., Dentone, C., Bassetti, M., Montesano, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137155 · Cited by 54 · see citing works

SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals

Lang‐Meli, J., Luxenburger, H., Wild, K., Karl, V., Oberhardt, V., Alizei, E. S., Graeser, A., Reinscheid, M., Roehlen, N., Reeg, D. B., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01106-y · Cited by 54 · see citing works

High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform

Bruno, P. M., Timms, R. T., Abdelfattah, N. S., Leng, Y., Lelis, F., Wesemann, D. R., Yu, X. G., & Elledge, S. J. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01566-x · Cited by 48 · see citing works

Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape

Nel, A. E., & Miller, J. F. (2021) · ACS Nano · doi:10.1021/acsnano.1c01845 · Cited by 50 · see citing works

Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients

Khoo, N. K. H., Lim, J. M. E., Gill, U. S., de Alwis, R., Tan, N., Toh, J. Z. N., Abbott, J. E., Usai, C., Ooi, E. E., Low, J. G. H., et al. (2022) · Med · doi:10.1016/j.medj.2021.12.004 · Cited by 47 · see citing works

Current Vaccine Platforms in Enhancing T-Cell Response

Ura, T., Takeuchi, M., Kawagoe, T., Mizuki, N., Okuda, K., & Shimada, M. (2022) · Vaccines · doi:10.3390/vaccines10081367 · Cited by 50 · see citing works

Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status

Yu, E. D., Wang, E. W., Garrigan, E., Goodwin, B., Sutherland, A., Tarke, A., Chang, J., Gálvez, R. I., Mateus, J., Ramirez, S. I., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.003 · Cited by 45 · see citing works

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection

Moga, E., Lynton‐Pons, E., & Domingo, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904686 · Cited by 46 · see citing works

CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2

Hoffmann, D., Corleis, B., Rauch, S., Roth, N., Mühe, J., Halwe, N. J., Ulrich, L., Fricke, C., Schön, J., Kraft, A., et al. (2021) · doi:10.1101/2021.03.22.435960 · Cited by 48 · see citing works

Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19

Heide, J., Schulte, S., Kohsar, M., Brehm, T. T., Herrmann, M., Karsten, H., Marget, M., Peine, S., Johansson, A. M., Sette, A., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009842 · Cited by 46 · see citing works

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

Nagler, A., Kalaora, S., Barbolin, C., Gangaev, A., Ketelaars, S. L. C., Alon, M., Pai, J. A., Benedek, G., Yahalom-Ronen, Y., Noam Erez, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109305 · Cited by 46 · see citing works

A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients

Bieberich, F., Vazquez-Lombardi, R., Yermanos, A., Ehling, R. A., Mason, D. M., Wagner, B., Kapetanovic, E., Roberto, R. B. D., Weber, C. R., Savic, M., et al. (2021) · bioRxiv · doi:10.3389/fimmu.2021.701085 · Cited by 39 · see citing works

Performance of the T-SPOTⓇ.COVID test for detecting SARS-CoV-2-responsive T cells

Kruse, M., Dark, C., Aspden, M., Cochrane, D., Competiello, R., Peltz, M., Torres, L., Wrighton-Smith, P., & Dudek, M. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.073 · Cited by 42 · see citing works

Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection

Wagner, K. I., Mateyka, L. M., Jarosch, S., Grass, V., Weber, S., Schober, K., Hammel, M., Burrell, T., Kalali, B. N., Poppert, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110214 · Cited by 45 · see citing works

Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain

Yang, L., Beek, M. V., Wang, Z., Muecksch, F., Canis, M., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., & Chakraborty, A. K. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112256 · Cited by 46 · see citing works

The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses

Antunes, R. D. S., Weiskopf, D., Sidney, J., Rubiro, P., Peters, B., Arlehamn, C. S. L., Grifoni, A., & Sette, A. (2023) · Current Protocols · doi:10.1002/cpz1.934 · Cited by 46 · see citing works

Template switching and duplications in SARS-CoV-2 genomes give rise to insertion variants that merit monitoring

Garushyants, S. K., Rogozin, I. B., & Koonin, E. V. (2021) · Communications Biology · doi:10.1038/s42003-021-02858-9 · Cited by 45 · see citing works

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases- Tarke et al., 2021

Grifoni, A. (2021) · Data Archiving and Networked Services (DANS) · doi:10.17632/xjzk7gg8b7

Parallel detection of SARS‐CoV ‐2 epitopes reveals dynamic immunodominance profiles of CD8 + T memory cells in convalescent COVID ‐19 donors

van den Dijssel, J., Hagen, R. R., de Jongh, R., Steenhuis, M., Rispens, T., Geerdes, D. M., Mok, J. Y., Kragten, A. H., Duurland, M. C., Verstegen, N. J. M., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1423 · Cited by 24 · see citing works

Beyond Spike: Identification of nine highly prevalent SARS-CoV-2-specific CD8 T-cell epitopes in a large Norwegian cohortPreprint

Meyer, S., Blaas, I., Bollineni, R. C., Delić-Šarac, M., Tran, T. T., Knetter, C. F., Dai, K., Madssen, T. S., Vaage, J. T., Gustavsen, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.13.463911 · Cited by 2 · see citing works

COVID-19 Patients Form Memory CD8+ T Cells that Recognize a Small Set of Shared Immunodominant Epitopes in SARS-CoV-2Preprint

Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N. H., Perullo, C. R., Cristofaro, A. W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3669387 · Cited by 12 · see citing works

Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein

Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N., Perullo, C. R., Cristofaro, A. W., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.006 · Cited by 318 · see citing works